MX9301546A - Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado - Google Patents

Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado

Info

Publication number
MX9301546A
MX9301546A MX9301546A MX9301546A MX9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A
Authority
MX
Mexico
Prior art keywords
receptor
manufacture
preparation
pharmaceutical preparation
preparation containing
Prior art date
Application number
MX9301546A
Other languages
English (en)
Inventor
Werner Mederski
Dieter Dorsch
Rolf Gericke
Manfred Baumgarth
Pierre Schelling
Rolf Bergmann
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX9301546A publication Critical patent/MX9301546A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un nuevo preparado farmacéutico conteniendo un canal activador de potasio ('KKA') y un receptor antagonista de la angiotensina II ('AR').
MX9301546A 1992-03-20 1993-03-19 Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado MX9301546A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4209071A DE4209071A1 (de) 1992-03-20 1992-03-20 Pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
MX9301546A true MX9301546A (es) 1993-09-01

Family

ID=6454609

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301546A MX9301546A (es) 1992-03-20 1993-03-19 Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado

Country Status (13)

Country Link
EP (1) EP0561357A1 (es)
JP (1) JPH0648961A (es)
KR (1) KR930019215A (es)
CN (1) CN1076357A (es)
AU (1) AU3528593A (es)
CA (1) CA2091942A1 (es)
DE (1) DE4209071A1 (es)
HU (1) HUT63764A (es)
MX (1) MX9301546A (es)
NO (1) NO931014L (es)
PL (1) PL298159A1 (es)
TW (1) TW237384B (es)
ZA (1) ZA931984B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
DE4004268A1 (de) * 1990-02-13 1991-08-14 Merck Patent Gmbh Pharmazeutische zubereitung

Also Published As

Publication number Publication date
AU3528593A (en) 1993-09-23
KR930019215A (ko) 1993-10-18
TW237384B (es) 1995-01-01
ZA931984B (en) 1993-10-19
JPH0648961A (ja) 1994-02-22
EP0561357A1 (de) 1993-09-22
CN1076357A (zh) 1993-09-22
NO931014L (no) 1993-09-21
CA2091942A1 (en) 1993-09-21
NO931014D0 (no) 1993-03-19
DE4209071A1 (de) 1993-09-23
HUT63764A (en) 1993-10-28
HU9300796D0 (en) 1993-06-28
PL298159A1 (en) 1993-10-18

Similar Documents

Publication Publication Date Title
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
TW239126B (es)
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
LU91206I2 (fr) Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel)
EP0744942A4 (en) HYDROGEL FORMULATION WITH CONTROLLED RELEASE
TR200001603T2 (tr) Yeni bileşikler
UA41909C2 (uk) Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат
ES8704946A1 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
AU661831B2 (en) 8-ene-19, 11beta -bridged steroids, their preparation and pharmaceutical formulations containing them
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
MX9301546A (es) Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado
TW252979B (es)
TW261605B (es)
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
GR3030731T3 (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
MX9710002A (es) Nuevo uso medico.